Summary
Audentes Therapeutics operates as a biotechnology company. The Company focuses on the development and commercialization of gene therapy treatments for people with serious rare diseases.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Senior Management
Matthew R Patterson
Chairman and CEO
Tom Soloway
CFO
Natalie C Holles
President and COO
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy